Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FYX17
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,358
Award facts
- Contract value 100% obligated
- $17,357.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $17,357.75 by the Defense Logistics Agency for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, issued on July 18, 2025, is scheduled for completion by August 8, 2025. The award carries no set-aside designation, demonstrating the vendor's competitive strength in federal procurement. This delivery order is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities.
As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and medical supplies to Department of Defense healthcare sites nationwide. The Nexplanon implants being delivered under this order represent contraceptive devices within the company's broader pharmaceutical portfolio, which encompasses branded and generic prescription drugs, biologics, and medical consumables. The Defense Logistics Agency utilizes this extensive IDC vehicle to maintain consistent pharmaceutical supply capabilities across military health facilities, ensuring availability of essential medications and medical devices critical to military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FYX17?
SPE2DB25FYX17 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FYX17 worth?
The government has obligated $17,358 on SPE2DB25FYX17.
Is contract SPE2DB25FYX17 an order under another contract?
Yes. SPE2DB25FYX17 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX17 competed?
The extent of competition for SPE2DB25FYX17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award